Sarah Glewis is a Senior Clinical Pharmacogenomics Pharmacist at Peter MacCallum Cancer Centre and a PhD Candidate at the University of Melbourne, Australia. Her current research efforts focus on clinical Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) for the treatment and supportive care of cancer. She is the principal investigator for the first PGx multisite clinical trial in Australia (PACIFIC-PGx) and program manager for the follow-on trial with expanded PGx testing and TDM (PRECISION). She was awarded a research grant from ISOPP to support her PGx research work extending to regional areas in Australia and her work in PGx has been recognised in the Victorian HealthCare Award in Australia.